WO2024150067 - ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF
National phase entry is expected:
Publication Number
WO/2024/150067
Publication Date
18.07.2024
International Application No.
PCT/IB2024/000021
International Filing Date
12.01.2024
Title **
[English]
ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF
[French]
RÉACTIONS DE CONDENSATION D'ACYLOÏNE, ENZYMES ET PRODUITS ASSOCIÉS
Applicants **
MOJIA BIOTECH PTE. LTD.
6 Raffles Quay, #14-06
Singapore 048580, SG
Inventors
GONZALEZ, Ramon
6314 W Maclaurin Dr.
Tampa, FL 33647, US
LEE, Seung, Hwan
3802 Spectrum Blvd.
Suite 100
Tampa, FL 33612-9220, US
ZHU, Fayin
3802 Spectrum Blvd.
Suite 100
Tampa, FL 33612-9220, US
Priority Data
63/479,606
12.01.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 5041 | |
| EPO | Filing, Examination | 67822 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 21460 |

Total: 95495 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
methods.[French]
L'invention comprend de nouveaux itinéraires de synthèse qui impliquent l'utilisation d'une réaction de condensation d'acyloïne entre une cétone et du formyl-CoA pour former des 2-hydroxyacyl-CoA ramifiés correspondants et la formation de produits à chaîne ramifiée à partir de ceux-ci. L'invention concerne des micro-organismes génétiquement modifiés qui produisent un produit ramifié à partir d'une cétone et de formyl-CoA et des procédés de production d'un produit ramifié, comprenant des procédés in vivo et in vitro.